Hims & Hers Health is trading 5.21% lower at €25.84 amid a broader risk-off session, with the Nasdaq Composite down 0.98% and the S&P 500 down 0.50%.
- Shares gained 9.83% on September 22, so profit-taking may also be contributing; this is not independently confirmed.
- No fresh company announcement clearly explains the September 23 decline.
- Securities-fraud lawsuit coverage remains a negative overhang, but available reports do not link it directly to today’s move.